The Pharmacovigilance Market focuses on the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other medicine-related problem. Clinical trials provide essential safety and efficacy data before approval, yet they cover only a limited number of patients for relatively short periods. Continuous monitoring after products reach the...

Market Overview The Global Pharmacovigilance and Drug Safety Software Market reached US$ 1.2 billion in 2023 and is expected to reach US$ 2.5 billion by 2031, growing with a CAGR of 9.5% during the forecast period 2024-2031. Pharmacovigilance and drug safety software are essential for managing global drug safety data, focusing on identifying, reporting, and handling adverse drug reactions. This...

Market Overview The Global Pharmacovigilance and Drug Safety Software Market reached US$ 1.2 billion in 2023 and is expected to reach US$ 2.5 billion by 2031, growing with a CAGR of 9.5% during the forecast period 2024-2031. Pharmacovigilance and drug safety software are essential for managing global drug safety data, focusing on identifying, reporting, and handling adverse drug reactions. This...